The white ring sign is useful for differentiating between fundic gland polyps and gastric adenocarcinoma of the fundic gland type

Abstract

Background and study aims Gastric adenocarcinoma of the fundic gland type (GA-FG) is characterized by an elevated lesion with vessel dilation exhibiting branching architecture (DVBA). However, this feature is also found in fundic gland polyps (FGPs), posing a challenge in their differentiation. In this study, we aimed to investigate the clinicopathological features of gastric elevated lesions with DVBA and assess the efficacy of the white ring sign (WRS) as a novel marker for distinguishing between FGPs and GA-FGs.

Methods We analyzed 159 gastric elevated lesions without DVBA and 51 gastric elevated lesions with DVBA, further dividing the latter into 39 in the WRS-positive group and 12 in the WRS-negative group. The clinicopathological features, diagnostic accuracy, and inter-rater reliability were analyzed.

Results Univariate and multivariate analyses for gastric elevated lesions with DVBA identified the histological type consistent with FGPs and GA-FGs, along with the presence of round pits in the background gastric mucosa, as independent predictors. FGPs were present in 92.3% (36/39) of the WRS-positive group and GA-FGs were observed in 50.0% (6/12) of the WRS-negative group. WRS positivity and negativity exhibited high diagnostic accuracy, with 100% sensitivity, 80.0% specificity, and 94.1% accuracy for FGPs, and 100% sensitivity, 86.7% specificity, and 88.2% accuracy for GA-FGs. Kappa values for WRS between experts and nonexperts were 0.891 and 0.841, respectively, indicating excellent agreement.

Conclusions WRS positivity and negativity demonstrate high diagnostic accuracy and inter-rater reliability for FGPs and GA-FGs, respectively, suggesting that WRS is a useful novel marker for distinguishing between FGPs and GA-FGs.

Keywords

Endoscopy Upper GI Tract - Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE) - Endoscopic resection (ESD, EMRc, ...) - Precancerous conditions & cancerous lesions (displasia and cancer) stomach

Publication History

Received: 06 August 2023

Accepted after revision: 03 April 2024

Accepted Manuscript online:
08 April 2024

Article published online:
06 June 2024

• References

• 1 Kim JH, Cheung DY. Must-Have Knowledge about the Helicobacter pylori-negative gastric cancer. Gut Liver 2016; 10: 157 DOI: 10.5009/gnl16002. (PMID: 26934879)
• 2 Yamamoto Y, Kikuchi D, Nagami Y. et al. Management of adverse events related to endoscopic resection of upper gastrointestinal neoplasms: Review of the literature and recommendations from experts. Digest Endosc 2019; 31: 4-20
• 3 Ueyama H, Matsumoto K, Nagahara A. et al. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2013; 46: 153-157 DOI: 10.1055/s-0033-1359042. (PMID: 24338239)
• 4 Takahashi K, Ueno N, Sasaki T. et al. Long-term observation of gastric adenocarcinoma of fundic gland mucosa type before and after Helicobacter pylori eradication: a case report. J Gastric Cancer 2021; 21: 103
• 5 Iwamuro M, Kusumoto C, Nakagawa M. et al. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type. Sci Rep 2021; 11: 7375 DOI: 10.1038/s41598-021-86893-w. (PMID: 33795810)
• 6 Meng X, Yang G, Dong C. et al. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021; 13: 203636132110601 DOI: 10.1177/20363613211060171. (PMID: 34925726)
• 7 Chiba T, Kato K, Masuda T. et al. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings: Gastric adenocarcinoma of fundic gland. Digest Endosc 2016; 28: 722-730 DOI: 10.1111/den.12676. (PMID: 27129734)
• 8 Benedict MA, Lauwers GY, Jain D. Gastric adenocarcinoma of the fundic gland type. Am J Clin Pathol 2018; 149: 461-473 DOI: 10.1093/ajcp/aqy019. (PMID: 29648578)
• 9 Carmack SW, Genta RM, Schuler CM. et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009; 104: 1524-1532 DOI: 10.1038/ajg.2009.139. (PMID: 19491866)
• 10 Shaib YH, Rugge M, Graham DY. et al. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol 2013; 11: 1374-1384 DOI: 10.1016/j.cgh.2013.03.019. (PMID: 23583466)
• 11 Ueyama H, Matsumoto K, Yao T. et al. Endoscopic features of gastric adenocarcinoma of fundic-gland type. Stomach and Intestine 2020; 55: 1006-1021
• 12 Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112
• 13 Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Digest Endosc 2015; 27: 735-74214 DOI: 10.1111/den.12483. (PMID: 25923666)
• 14 Yagi K, Nozawa Y, Endou S. et al. Diagnosis of early gastric cancer by magnifying endoscopy with NBI from viewpoint of histological imaging: mucosal patterning in terms of white zone visibility and its relationship to histology. Diagn Ther Endosc 2012; 2012: 1-7
• 15 Takahashi K, Fujiya M, Ichihara S. et al. Inverted gastric adenocarcinoma of fundic gland mucosa type colliding with well differentiated adenocarcinoma: A case report. Medicine 2017; 96: e7080
• 16 Imamura K, Yao K, Nimura S. et al. Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type. Gastric Cancer 2021; 24: 1307-131917 DOI: 10.1007/s10120-021-01208-2. (PMID: 34241719)
• 17 Matsumoto K, Ueyama H, Yao T. et al. Endoscopic features of gastric epithelial neoplasm of fundic gland mucosa lineage. Diagnostics 2022; 12: 2666 DOI: 10.3390/diagnostics12112666. (PMID: 36359508)
• 18 Muto M, Yao K, Kaise M. et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA?G). Digest Endosc 2016; 28: 379-393 DOI: 10.1111/den.12638. (PMID: 26896760)